Cargando…
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease)
Psoriasis is a chronic inflammatory skin disease that involves numerous types of immune cells and cytokines resulting in an inflammatory feedback loop and hyperproliferation of the epidermis. A more detailed understanding of the underlying pathophysiology has revolutionized anti-psoriatic treatment...
Autores principales: | Benezeder, Theresa, Wolf, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881414/ https://www.ncbi.nlm.nih.gov/pubmed/31673756 http://dx.doi.org/10.1007/s00281-019-00766-z |
Ejemplares similares
-
Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009) -
Furin Expression in Patients With Psoriasis—A Patient Cohort Endangered to SARS-COV2?
por: Graier, Thomas, et al.
Publicado: (2021) -
Phosphorylation of a reinitiation supporting protein, RISP, determines its function in translation reinitiation
por: Mancera-Martínez, Eder, et al.
Publicado: (2021) -
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
por: Benezeder, Theresa, et al.
Publicado: (2020) -
Putting a cap on reinitiation
por: LeBrasseur, Nicole
Publicado: (2002)